Schneiderian papillomas are uncommon benign tumors of the sinonasal area. They are prone to local aggressiveness and recurrence, and some undergo malignant progression. We analyzed specimens obtained from 67 Chinese patients who had presented to the ENT department of a regional hospital with biopsy-proven schneiderian papilloma. Seven of these patients had either synchronous or metachronous carcinoma, 1 of whom had pure carcinoma in situ. For each case, we documented the morphology, immunohistochemical expression of tumor suppressor genes p53 and p16, and any association with human papillomavirus (HPV) infection as detected by either polymerase chain reaction or in situ hybridization techniques. We found that severe dysplasia and p53 positivity were strongly associated with malignant progression. Association with HPV was demonstrated in 22 of the 67 patients (33%); the association was strongest among patients with exophytic papillomas and carcinomas. The effect of HPV in papilloma oncogenesis probably begins during the early phase, while other factors are responsible for progression to carcinoma. We conclude that p53-positive, dysplastic schneiderian papillomas warrant aggressive surgical treatment.
Introduction
Schneiderian papillomas are uncommon benign tumors that arise from the ectodermal schneiderian membrane of the sinonasal area (fi gure 1, A). 1 They are covered with squamous, respiratory, or transitional cells, and they are different from keratinizing squamous papillomas that arise from the nasal vestibule. Most of these papillomas are inverted papillomas with a predominantly endophytic growth pattern. A small proportion belongs to two subtypes of papilloma: exophytic (fungiform) and oncocytic (cylindrical). Schneiderian papillomas present with local symptoms such as nasal obstruction and epistaxis. They are prone to local aggressiveness and recurrence, and some undergo malignant progression. The reported incidence of malignant change in inverted papillomas ranges from 2 to 27%. 1 An association between schneiderian papillomas and human papillomavirus (HPV) infection has been documented by various centers and among different populations. [2] [3] [4] [5] However, reported rates of association span the entire spectrum from 0 to 100%. 1 Whether this broadest of ranges is attributable to genuine geographic variations (as has been documented with regard to tonsillar carcinomas 6 ) or to differences in methodology is open to question.
The mode of surgical treatment for schneiderian papillomas is controversial; the various options range from polypectomy, which often results in recurrence, to more radical excisions such as lateral rhinotomy and medial maxillectomy.
We analyzed specimens obtained from patients who had presented to our hospital with schneiderian papilloma or carcinoma. Our objective was to analyze the clinical fi ndings, microscopic morphology, follow-up data, and immunohistochemical expression of tumor suppressor genes p53 and p16, and to determine if there was any association with HPV infection. Emphasis was placed on elucidating the relationship of the study parameters with malignant progression. We hope that our fi ndings will have some bearing on determining the optimal mode of management for patients who harbor these tumors. (Note that p53 and p16 are italicized when we are referring to the genes and not italicized when we are referring to the expressed proteins.) 
Materials and methods
Sample collection and clinical data. We retrieved the biopsy specimens of all patients who had presented to our ENT department with schneiderian papilloma or carcinoma from January 1995 through December 2006. Two pathologists (F.M.F.C. and T.W.S.L.) reviewed the microscopic morphology of hematoxylin and eosin-stained histologic sections. We classifi ed the papillomas according to their confi guration into one of three subtypes: inverted, exophytic, or oncocytic. We then stratifi ed their degree of epithelial cell dysplasia as absent (fi gure 1, B), mild, moderate, or severe (fi gure 1, C). We also noted whether a carcinoma had been diagnosed simultaneously with the papillomas (synchronous presentation) or if one had arisen sometime later (metachronous presentation).
We also recorded information on recurrence, malignant progression, and patient outcomes that had been compiled during a follow-up of 2 to 12 years.
Immunohistochemistry. Immunohistochemical stains for p53 and p16 INK4A were performed on selected sections of formalin-fi xed, paraffi n-embedded biopsy tissue. Ten non-neoplastic infl ammatory nasal polyps were taken as comparison controls (fi gure 1, D). Paraffi n sections of 4 µm were immunostained with monoclonal antibodies p53 (Clone DO-7; Dako; Carpenteria, Calif.) and p16 (Clone 6H12; Novocastra; Melbourne, Australia) on a LabVision Autostainer 480 (Lab Vision Corp.; Fremont, Calif.) after they had been pressure-cooked at 120°C for 90 seconds in 0.01M citrate buffer (pH 7.6). LP Value (Lab Vision Corp.) and diaminobenzidine were used as the detection system and the chromogen.
The immunostained sections were then examined separately by the two pathologists according to the same criteria. For p53, only moderate to heavy nuclear staining in more than 10% of cells was considered positive. For p16, a positive fi nding required nuclear staining with or without cytoplasmic staining; intensity was not evaluated. Any lesion with 10% or more epithelial cells showing confl uent staining was recorded as positive.
HPV detection by polymerase chain reaction. Polymerase chain reaction (PCR) for HPV viral DNA was carried out on the same batch of control specimens as was used for immunohistochemistry. HPV typing was also performed whenever possible. DNA was extracted from fi ve 10-µm paraffi n sections by digestion in proteinase K solution (0.06 U/µl) at 55°C overnight. DNA quantity and quality were assessed by ultraviolet spectrophotometric analysis at 260 and 280 nm. DNA of the sample was diluted to a concentration of 300 ng/ µl before PCR amplifi cation or storage. The quality of each DNA sample was verifi ed by amplifying portions of the ubiquitous human beta-globin gene with two primer pairs: GH20 and PCO4 (yielding a 268-bp fragment). Successful amplifi cation of the beta-globin gene fragments indicated that the DNA sample was adequate for PCR analysis and that no PCR inhibitors were present. Two pairs of consensus primers (MY and GP6) were used. The sample DNA from biopsies was amplifi ed in 50-µl reaction volume containing 10 mmol/L of Tris, 1.5 mmol/L of MgCl 2 for the MY primers and 2.0 mmol/L of MgCl 2 for the GP6 primers, 100 µmol/L each of deoxynucleotide triphosphate, 0.5 µmol/L of each primer, and 0.2 U of AmpliTaq polymerase; the pH level was 8.5. DNA amplifi cation was performed by an initial precycling denaturation held at 95°C for 10 minutes followed by 43 cycles of PCR. Each cycle consisted of a denaturation step (95°C for 30 sec), an annealing step (55°C for 30 sec for the MY primers and 50°C for 30 sec for the GP primers), and an extension step (72°C for 1 min). A 10-µl aliquot was then run on a 2% agarose gel, stained with GelStar, and viewed under ultraviolet light.
HPV typing was performed by restriction-fragmentlength polymorphism. Aliquots of 6 µl of the 450-bp MY primer PCR product were digested with 10 U of the respective restriction enzyme, HaeIII, CfoI, EcoRI, HpaII, PstI, HinFI, RsaI, and its specifi c buffer in a total volume of 30 µl at 37°C for 1 hour. The products of digestion were separated by electrophoresis in 4% NuSieve agarose gel stained with GelStar.
HPV detection by in situ hybridization. In situ hybridization for HPV was performed on all PCR-positive cases for confi rmatory purposes. One case each of cervical intraepithelial neoplasia (CIN) II and cervical squamous carcinoma was taken to serve as a positive control. The HPV in situ hybridization was performed according to the manufacturer's recommendation. Briefl y, 4-µm rehydrated paraffi n sections were treated with 0.8% pepsin in 0.2N HCl at 37°C for 5 minutes and then with 0.3% H 2 O 2 in methanol for 20 minutes. A wide-spectrum biotinylated HPV DNA probe (Dako) for types 6, 11, 16, 18, 31, 33, 35, 39, 45, 51 , and 52 was added to the air-dried section and denatured at 92°C for 5 minutes. Hybridization was carried out at 37°C for 18 hours. After the cover glass was removed, the slides were washed with a stringency wash solution at 48°C for 30 minutes. The hybridization signal was detected by the GenPoint tyramide signal amplifi cation system (Dako).
Statistical methods. We used the commercially available SPSS 16.0 and Mystat 12 statistical software packages for statistical analyses. Simple chi-square tests were used for nominal data, and the Fisher exact test was used whenever the frequency was low (≤5). The studies of trends were performed by fi rst visually analyzing individual scatter plots and then calculating various correlation coeffi cients (such as the Pearson correlation coeffi cient and the Spearman correlation coeffi cient). Binary logistic regression was used for exploratory studies of the various factors involved in identifying benignity and malignancy as independent variables. Various methods of modeling, including the "forced entry method" with both the backward and forward "stepwise method," were sequentially applied. In all analyses, p ≤ 0.05 was considered statistically signifi cant.
Results
During the study time frame, 67 patients-44 men and 23 women, aged 25 to 89 years (median: 60.5)-had presented with biopsy-proven schneiderian papillomas. Based on the major pattern of the biopsied material, 56 of these patients had inverted papillomas (84%), 8 had exophytic papillomas (12%), and 3 had oncocytic papillomas (4%).
The papillomas of 30 patients (45%) exhibited various degrees of dysplasia. Of these 30 cases, 14 were mild, 8
were moderate, and 8 were severe. Seven of the 8 severe cases were also associated with carcinoma: 3 cases of synchronous carcinoma and 4 cases of metachronous carcinoma. Among the 4 patients with metachronous carcinoma, the interval between the original presentation with papilloma and the diagnosis of carcinoma ranged from 3 months to 11 years (table 1) .
Of the 7 patients with carcinoma (table 1), 2 (patients 1 and 2) had either pure or predominant carcinoma in situ in which the epithelium showed a full-thickness loss of polarity, cellular anaplasia, or pleomorphism (fi gure 1, E). Patient 2 also had microinvasive early carcinoma. The carcinomas of the other 5 patients were classifi ed as squamous carcinomas arising from or associated with schneiderian papillomas (fi gure 1, F). The appearance of a predominantly papillary growth pattern (patient 4) and an inverted growth pattern (patient 6) was deceptive on low-power microscopic examination and could have been easily misidentifi ed as an exophytic or inverted papilloma. However, their cellular morphology, desmoplastic stroma, and destructive growth pattern betrayed their carcinomatous nature.
On the clinical side, the overall recurrence rate among the entire group (based on a minimum disease-free interval of 3 mo) was 52% (35 of 67); the rate was slightly Ancillary studies. P53 showed a remarkable reversed staining pattern compared with p16 (Pearson correlation, p < 0.001). All benign papillomas were negative for p53 (fi gure 2, A), except in 3 cases of moderate or Figure 2 . Immunohistochemical studies. A: P53 is negative in this schneiderian papilloma with no dysplasia. B: P53 is strongly expressed in carcinoma. C: P53 is expressed by dysplastic epithelium of the precursor papilloma in patient 5. D: P16 is expressed in a patchy confl uent manner in this schneiderian papilloma. Inset: Ribbon-like staining of superfi cial mucinous cells is seen. E: Precursor papilloma in patient 5 shows focal positive staining for p16 (upper half) 
and negative staining in dysplastic epithelium (lower half). F: Paradoxical expression of p16 by carcinoma in situ cells is seen in patient 1 (the non-neoplastic cells on the left are negative).

Discussion
Our study found a low incidence of schneiderian papillomas among our local Chinese population; on average, only 5 or 6 affected patients presented every year to our regional hospital, which serves a population of about 800,000. Patients managed by private ENT surgeons were not included in our analysis. Our fi ndings of onset during late adulthood (median age: 60.5 yr) and male preponderance are consistent with fi ndings in other populations. 1 Histologically, most cases represented inverted papillomas (84%). About 10% of them were associated with carcinoma at presentation or developing sometime later (median age: 65 yr). Within this carcinoma group, patient 1 had pure intraepithelial carcinoma in situ, and patient 2 had predominant carcinoma in situ with a minor microinvasive component. The other patients had frank squamous carcinoma evolving from or associated with an underlying papilloma. Because patients 1 and 2 had presented with early-stage malignancy, they fared better on follow-up in terms of recurrence, although patient 2 eventually died of a second cancer (colon cancer). Of the remaining 5 patients, 4 died of their disease, the exception being patient 5. The poor prognosis was attributable to repeated or uncontrollable local recurrence or distant metastasis. Therefore, adequate treatment of schneiderian papillomas before progression to malignancy is the best way to prevent cancer. Correlation with morphology shows that signifi cant dysplasia is associated with a higher risk of recurrence and progression to carcinoma. Identifying the high-risk group and ensuring complete excision serves to triage the patients. severe dysplasia. Five of the 7 carcinomas (the exceptions being cases 1 and 2) were positive (fi gure 2, B, and table 1) (Fisher exact test, p < 0.001). Patient 5 developed a carcinoma 11 years after her initial presentation with papilloma. The case of patient 5 is interesting because retrospective immunostudies for p53 showed that dysplastic epithelium in the fi rst papilloma specimen was positively stained (fi gure 2, C). The trend of p53 positivity with an increasing degree of dysplasia was highly signifi cant (Spearman correlation, p < 0.001). The 10 control cases showed isolated mild staining of basal cells (<10%) and were regarded as negative.
Immunohistochemical studies of the control specimens for p16 showed that superfi cial mucinous cells of non-neoplastic nasal polyps were positive in a nonspecifi c ribbon-like fashion (fi gure 2, D, inset). Foci of epithelial hyperplasia and squamous metaplasia were occasionally positive. Most of the schneiderian papillomas (57 of 60 [95%]) were distinctly positive in a patchy confl uent manner (fi gure 2, D, and 2, E, upper half). Severe dysplasia (fi gure 2, E, lower half) and squamous carcinomas (table 1) were negative. The reverse staining pattern with p53 is highlighted in fi gure 2, C, and fi gure 2, E. Paradoxically, the fi rst 2 cases of pure or predominant carcinoma in situ (fi gure 2, F) showed patchy strong staining.
HPV PCR was carried out on all 67 cases and 10 controls. All the controls were negative, which ruled out nonspecifi c contamination. The overall positive rate was 33% (22 of 67) (table 2). Positivity among the benign papillomas was highest in the exophytic group (86%) and absent in the oncocytic group (0%); 24% of inverted papillomas were positive. Typing was possible in only a few papillomas yielding types 6, 11, and a case of mixed types 11 and 33.
The carcinomas carried a slightly higher positive rate of 57% (patient 3 being type 11) (table 2). Typing was not done in most cases because of inadequate HPV DNA content. The difference between HPV positivity in carcinomas and papillomas was not statistically signifi cant (Fisher exact test). There was a notable lack of correlation in HPV PCR positivity with immunohistochemical staining for p16 (Pearson correlation, p = 0.848).
Wide-spectrum HPV in situ hybridization on all 24 PCR-positive cases showed isolated nuclear staining in only 5 cases, including 4 exophytic papillomas and 1 carcinoma (fi gure 3, A). This sparsely staining pattern In the uterine cervix, immunoexpression of p16 is often regarded as a surrogate marker of a high risk for HPV infection and high-grade CIN and cervical carcinoma. 7, 8 Such is not the case in patients with schneiderian papillomas. P16, a cyclin-dependent kinase 4 inhibitor and tumor suppressor gene, is focally expressed in nonneoplastic sinonasal mucosa of the infl ammatory nasal polyps. Expression of p16 has also been documented in normal respiratory epithelium by Schwerer et al. 9 We found a uniformly high rate of p16 expression in benign schneiderian papillomas in a patchy manner. P16 was notably not expressed in schneiderian carcinomas except for the 2 cases of pure or predominant carcinoma in situ (patients 1 and 2). Inactivation of p16 has previously been documented in head and neck squamous cell carcinomas. 10 This was attributed to p16 deletion or methylation. On the other hand, p53 protein expression coincided with the onset of severe dysplasia and most carcinomas. Therefore p53 serves as the better indicator of malignant progression, as has been reported in several other studies. [11] [12] [13] P53-positive dysplastic schneiderian papillomas defi nitely warrant more aggressive surgical treatment to prevent malignant progression.
HPV PCR was negative in all of the control cases. Low rates of positivity were also demonstrated by Yoskovitch et al in their studies of chronic sinusitis and normal nasal mucosa. 14 We were able to demonstrate the presence of HPV in 33% of our 67 cases, and the positivity rate varied among the different morphologic types, being highest in exophytic schneiderian papillomas. This fi nding is almost identical to that reported by Syrjänen in his review of 1,041 cases reported in the literature. 15 In our study, the association was slightly higher in the carcinoma group (57%) than in the entire group (52%), although the difference between the two was not statistically signifi cant. However, the HPV DNA content was so low that typing could not be performed in most cases. Low HPV DNA content was also borne out by the low pickup rate using wide-spectrum HPV in situ hybridization.
We can conclude that the role of HPV in the oncogenesis of schneiderian neoplasms differs from its role in cervical squamous carcinoma; in the latter, it plays the primary role with strong p16 expression and a high rate of HPV detection. The absence of p16 overexpression in most of our cases of schneiderian carcinoma indicates that mechanisms other than HPV integration are operating in cancer progression. Patients 1 and 2-who had pure and predominant carcinoma in situ, respectively-showed a unique marker expression (p16+, p53-, and HPV+) quite different from the frankly invasive squamous carcinoma. Such an expression points to a different oncogenic pathway-one with HPV possibly playing a stronger role. However, no fresh tissue from these patients is available for HPV E6/E7 mRNA transcript detection to confi rm this suspicion. Therefore, based on our immunohistochemical and molecular study fi ndings, we agree with Kim et al 2 and Katori et al 16 that HPV infection probably represents the initiation or early promotional event in the multistep oncogenesis of a signifi cant proportion of schneiderian papillomas. Subsequent genetic or epigenetic events act on them to bring about cellular dysplasia and progression to carcinoma. 
